The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Biotransformation of Sevoflurane
Abstract
Biotransformation of volatile anesthetics is of considerable interest because of known associations between metabolism of certain anesthetics and specific organ toxicities. For example, renal insufficiency after methoxyflurane anesthesia is intimately linked to the metabolism of this anesthetic [1]. One of the products of methoxyflurane metabolism, inorganic fluoride ion, has been implicated in the mechanism of methoxyflurane nephrotoxicity [2]. The fulminant hepatitis that occurs rarely after halothane anesthesia is related to the product of oxidative hepatic halothane metabolism, trifluoroacyl chloride, which binds to liver proteins forming trifluoroacetylated proteins, or neoantigens. In susceptible individuals, these neoantigens stimulate formation of antibodies that mediate hepatic destruction upon subsequent halothane exposure [3]. Biotransformation of every volatile anesthetic agent synthesized and/or introduced into clinical trials since methoxyflurane and halothane has been intensely scrutinized. Metabolism of sevoflurane, in vitro and in vivo, has been investigated in several animal species and in humans. Advances in enzyme biochemistry and molecular biology have illuminated similarities and differences between animal and human drug metabolizing enzymes, permitting both appropriate extrapolation of animal data to humans and reconciliation of discrepancies between animal and human sevoflurane studies. The relationship between sevoflurane metabolism and potential toxicity has been monitored extensively. There are now considerable data regarding sevoflurane metabolism and the absence to date of metabolism-based hepatic and renal toxicities in animals and humans. Indeed, studies of sevoflurane biotransformation may result in revision of some classically held concepts regarding volatile anesthetic metabolism and toxicity. General Like all fluorinated volatile anesthetics, sevoflurane undergoes biotransformation to organic and inorganic fluoride metabolites Figure 1. Cytochrome P-450-catalyzed sevoflurane oxidation at the fluoromethoxy carbon produces a transient intermediate that decomposes to inorganic fluoride and the organic fluoride metabolite hexafluoroisopropanol (HFIP) [4,5]. HFIP is the only organic fluoride metabolite of sevoflurane identified to date. Fluoride and HFIP are formed in equimolar amounts [6]. Substitution of deuterium for hydrogen on the fluoromethoxy carbon of sevoflurane markedly retards metabolism to fluoride and HFIP in vitro and in vivo, further suggesting that sevoflurane metabolism occurs almost exclusively on the fluoromethoxy carbon [6,7].Figure 1: Metabolism of sevoflurane. Major metabolites are inorganic fluoride and hexafluoroisopropanol (HFIP), which is subsequently glucuronidated.There is no evidence that HFIP undergoes further defluorination or oxidative (Phase I) metabolism. HFIP does undergo conjugation (Phase II metabolism) with glucuronic acid, forming HFIP-glucuronide, which is excreted in urine [4,5]. There is no evidence for HFIP toxicity at concentrations produced clinically, and HFIP is nonmutagenic in the Ames test (data on file at Abbott Laboratories, Abbott Park, IL). The chemical structure of sevoflurane, unlike that of other volatile anesthetics, dictates that it cannot undergo metabolism to an acyl halide. Sevoflurane metabolism does not result in the formation of trifluoroacetylated liver proteins [8] and therefore cannot stimulate the formation of antitrifluoroacetylated protein antibodies. The absence of sevoflurane modification of liver proteins by covalent binding has been demonstrated [8]. In this regard, sevoflurane differs from halothane, enflurane, and isoflurane, all of which are metabolized to reactive acyl halide intermediates. Desflurane may theoretically undergo metabolism to an acyl halide, based on its structure [9], although this has not been observed [8]. For anesthetics such as enflurane and isoflurane, acyl halides can bind to liver proteins, producing neoantigens that cross-react with antihalothane antibodies, provoking clinical cross-sensitization between these anesthetics [10]. Sevoflurane, because of its unique metabolism, would not be expected to produce such a reaction. Similarly, no other reactive intermediates resulting from sevoflurane biotransformation have been postulated or identified. The primary sevoflurane metabolites, fluoride and HFIP, are stable and do not appear to be reactive. Animal Investigations Inorganic fluoride is a metabolite common to the biotransformation of sevoflurane, as well as methoxyflurane, halothane, enflurane, isoflurane, and desflurane. Given the ubiquitous nature of this metabolite, coupled with the ease in measurement (using a fluoride-selective electrode), fluoride formation has been used as the most common index of volatile anesthetic biotransformation. In Vitro Studies Most in vitro animal investigations have compared rat hepatic microsomal metabolism of sevoflurane with that of other an
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fluoride Metabolites After Prolonged Exposure of Volunteers and Patients to Desflurane
Sutton, T. S., Koblin, D. D., Gruenke, L. D., Weiskopf, R. B., Rampil, I. J., Waskell, L., & Eger, E. I. (1991) · Anesthesia & Analgesia · doi:10.1213/00000539-199108000-00011 · Cited by 122
Cited by
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds
Johnson, B. M., Shu, Y.-Z., Zhuo, X., & Meanwell, N. A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01877 · Cited by 719
Motiwala, H. F., Armaly, A. M., Cacioppo, J. G., Coombs, T. C., Koehn, K. R. K., Norwood, V. M., & Aubé, J. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00749 · Cited by 593
Impact of Obesity on Drug Metabolism and Elimination in Adults and Children
Brill, M. J. E., Diepstraten, J., van Rongen, A., van Kralingen, S., van den Anker, J. N., & Knibbe, C. A. J. (2012) · Clinical Pharmacokinetics · doi:10.2165/11599410-000000000-00000 · Cited by 382
Global Warming Potential of Inhaled Anesthetics: Application to Clinical Use
Ryan, S. M., & Nielsen, C. J. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181e058d7 · Cited by 340
Update on Bispectral Index monitoring
Johansen, J. W. (2006) · Best Practice & Research Clinical Anaesthesiology · doi:10.1016/j.bpa.2005.08.004 · Cited by 313
Metadata
- Authors
- Kharasch, E. D.
- Venue
- Anesthesia & Analgesia
- Published
- 1995-12
- Volume
- 81
- Issue
- Supplement
- Pages
- 27S-38S
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W2087109562
- Cited by
- 162
- References
- 1
- FWCI
- 5.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biotransformation of Sevoflurane. https://app.cochat.ai/papers/10.1097/00000539-199512001-00005
- The paper
- Kharasch, E. D. (1995). Biotransformation of Sevoflurane. Anesthesia & Analgesia. https://doi.org/10.1097/00000539-199512001-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.